Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis

Clinical trial NCT04855617 · COMPLETED

Trial details

NCT number: NCT04855617
Sponsor: NYU Langone Health
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis

Start date: 2020-10-26
Primary completion: 2022-10-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.